Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses

Journal of Immunology

Volumn 161, Issue 11, 1998, Pages 6347-6355

  Müller Newen, Gerhard ^a   Küster, Andrea ^a   Hemmann, Ulrike ^a   Keul, Radovan ^a   Horsten, Ursula ^a   Martens, Astrid ^a   Graeve, Lutz ^a   Wijdenes, John ^b   Heinrich, Peter C ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Diaclone   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6 RECEPTOR; RECOMBINANT INTERLEUKIN 6;

ANIMAL CELL; ARTICLE; BACULOVIRUS; GEL FILTRATION; IMMUNOAFFINITY CHROMATOGRAPHY; INSECT; MOLECULAR WEIGHT; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD; BACULOVIRIDAE; CELL LINE; CELL MEMBRANE; COS CELLS; CYTOKINE RECEPTOR GP130; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HUMANS; INTERLEUKIN-6; KIDNEY; MACROMOLECULAR SUBSTANCES; MEMBRANE GLYCOPROTEINS; RECEPTORS, INTERLEUKIN-6; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SOLUBILITY; SPODOPTERA;

EID: 0038739858     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1.
2. Hirano, T., T. Taga, N. Nakano, K. Yasukawa, S. Kashiwamura, K. Shimizu, K. Nakajima, K. H. Pyun, and T. Kishimoto. 1985. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSF-2). Proc. Natl. Acad. Sci. USA 82:5490.
3. Takai, Y., G. G. Wong, S. C. Clark, S. Burakoff, and S. J. Hermann. 1988. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J. Immunol. 140:508.
4. Gauldie, J., C. Richards, D. Harnish, P. Lansdorp, and H, Baumann. 1987. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84:7251.
5. Andus, T., T. Geiger, T. Hirano, H. Northoff, U. Ganter, J. Bauer, T. Kishimoto, and P. C. Heinrich. 1987. Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett. 221:18.
6. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Köhler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339.
7. Kawano, M., T. Hirano, T. Matsuda, T. Taga, Y. Horii, K. Iwato, H. Asaoku, B. Tang, O. Tanabe, H. Tanaka, A. Kuramoto, and T. Kishimoto. 1988. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83.
8. Hirano, T., T. Matsuda, M. Turner, N. Miyasaka, G. Buchan, B. Tang, K. Sato, M. Shimizu, R. Maini, M. Feldman, and T. Kishimoto. 1988. Excessive production of interleukin-6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur. J. Immunol. 18:1797.
9. Yoshizaki, K., T. Matsuda, N. Nishimoto, T. Kuritani, I. Tacho, K. Aozasa, T. Nakahata, H. Kawai, H. Togo, T. Komori, S. Kishimoto, T. Hirano, and T. Kishimoto. 1989. Pathological significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74:1360.
10. Jilka, R. L., G. Hangoc, G. Girasole, G. Passeri, D. C. Williams, J. S. Abrams, B. Boyce, H. Broxmeyer, and S. C. Manolagas. 1992. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88.
11. Murakami, M., M. Hibi, N. Nakagawa, T. Nakawaga, K. Yasukawa, K. Yamanishi, T. Taga, and T. Kishimoto. 1993. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260:1808.
12. Lütticken, C., U. M. Wegenka, J. Yuan, J. Buschmann, C. Schindler, A. Ziemiecki, A. G. Harpur, A. F. Wilks, K. Yasukawa, T. Taga, T. Kishimoto, G. Barbieri, S. Pellegrini, M. Sendtner, P. C. Heinrich, and F. Horn. 1994. Association of transcription factor APRF and protein kinase JAK1 with the interleukin-6 signal transducer gp130. Science 263:89.
13. Stahl, N., T. J. Farrugella, T. G. Boulton, Z. Zhong, J. E. Darnell, Jr., and G. D. Yancopoulos. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1349.
14. Wegenka, U. M., J. Buschmann, C. Lütticken, P. C. Heinrich, and F. Horn. 1993. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell. Biol. 13:276.
15. Nakafuku, M., T. Satoh, and Y. Kaziro. 1992. Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active Ras-GTP complex in rat pheochromocytoma PC12 cells. J. Biol. Chem. 267:19448.
16. shc, Raf-I, and MEK-1 in the IL-6-induced mitogen-activated protein cascade of a growth-responsive B cell line. J. Immunol. 153:4436.
17. Matsuda, T., T. Fukada, M. Takahashi-Tezuka, Y. Okuyama, Y. Fujitani, Y. Hanazono, H. Hirai, and T. Hirano. 1995. Activation of fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J. Biol. Chem. 270:11037.
18. Matsuda, T., M. Takahashi-Tezuka, T. Fukada, Y. Okuyama, Y. Fujitani, S. Tsukada, H. Mano, H. Hirai, O. N. Witte, and T. Hirano. 1995. Association and activation of btk and tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 85:627.
19. Taga, T., M. Hibi, Y. Hirata, K. Yamasaki, K. Yasukawa, T. Matsuda, T. Hirano, and T. Kishimoto. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573.
20. Narazaki, M., K. Yasukawa, T. Saito, Y. Ohsugi, H. Fukui, Y. Koishihara, G. D. Yancopoulos, T. Taga, and T. Kishimoto. 1993. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 82:1120.
21. Honda, M., S. Yamamoto, M. Cheng, K. Yasukawa, H. Suzuki, T. Saito, Y. Usugi, T. Tokunaga, and T. Kishimoto. 1992. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J. Immunol. 148:2175.
22. Arcone, R., P. Pucci, F. Zappacosta, V. Fontaine, A. Malorni, G. Marino, and G. Ciliberto. 1991. Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector. Eur. J. Biochem. 198:541.
23. Aarden, L. A., E. R. De Groot, O. L. Schaap, and P. M. Lansdorp. 1987. Production of hybridoma growth factor by human monocytes. Eur J. Immunol. 17:1411.
24. Weiergräber, O., U. Hemmann, A. Küster, G. Müller-Newen, J. Schneider, S. Rose-John, P. Kurschat, J. P. J. Brakenhoff, M. H. L. Hart, S. Stabel, and P. C. Heinrich. 1995. Soluble human interleukin-6 receptor: expression in insect cells, purification and characterization. Eur. J. Biochem. 234:661.
25. Wijdenes, J., P. C. Heinrich, G. Müller-Newen, C. Roche, G. Zong-Jiang, C. Clement, and B. Klein. 1995. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 mAbs. Eur. J. Immunol. 25:3474.
26. Müller-Newen, G., C. Köhne, R. Keul, U. Hemmann, W. Müller-Esterl, J. Wijdenes, J. P. J. Brakenhoff, M. H. L. Hart, and P. C. Heinrich. 1996. Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. Eur. J. Biochem. 236:837.
27. 125I-containing acylating agent. Biochem. J. 133:529.
28. Horsten, U., G. Müller-Newen, C. Gerhartz, A. Wollmer, J. Wijdenes, P. C. Heinrich, and J. Grötzinger. 1997. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6)/IL-6 receptor/gp130 complex. J. Biol. Chem. 272:23748.
29. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456.
30. Wegenka, U. M., C. Lütticken, J. Buschmann, J. Yuan, F. Lottspeich, W. Müller-Esterl, C. Schindler, E. Roeb, P. C. Heinrich, and F. Horn. 1994. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transduction and transcription (Stat) factor family. Mol. Cell. Biol. 14:3186.
31. Kyhse-Anderson, J. 1984. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins form polyacrylamide to nitro-cellulose. J. Biochem. Biophys. Methods 10:203.
32. May, L. T., H. Viguet, J. S. Kenney, N. Ida, A. C. Allison, and P. B. Sehgal. 1992. High levels of "complexed" interleukin-6 in human blood. J. Biol. Chem. 267: 19698.
33. Ndubuisi, M. I., K. Patel, R. J. Rayanade, A. Mittelman, L. T. May, and P. B. Sehgal. 1998. Distinct classes of chaperoned IL-6 in human blood: differential immunological and biological activity. J. Immunol. 160:494.
34. Müllberg, J., H. Schooltink, T. Stoyan, M. Günther, L. Graeve, G. Buse, A. Mackiewicz, P. C. Heinrich, and S. Rose-John. 1993. The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23:473.
35. Müllberg, J., E. Dittrich, L. Graeve, C. Gerhartz, K. Yasukawa, T. Taga, T. Kishimoto, and P. C. Heinrich Rose-Fohn. 1993. Differential shedding of the two subunits of the interleukin-6 receptor. FEBS Lett. 332:174.
36. Lust, J. A., K. A. Donovan, M. P. Kline, P. R. Greipp, R. A. Kyle, and N.J. Maihle. 1992. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4:96.
37. Diamant, M., K. Rieneck, N. Mechti, X.-G. Zhang, M. Svenson, K. Bendtzen, and B. Klein. 1997. Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human IL-6 signal transducer gp130. FEBS Lett. 412:379.
38. Salvati, A. L., A. Lahm, G. Paonessa, G. Ciliberto, and C. Toniatti. 1995. Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor α mutated in the predicted gp130-binding interface. J. Biol. Chem. 270:12242.
39. Ehlers, M., F. D. de Hon, K. H. Bos, U. Horsten, G. Kurapkat, H. Schmitz van De Leur, J. Grötzinger, A. Wollmer, J. P. J. Brakenhoff, and S. Rose-John. 1995. Combining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cells. J. Biol. Chem. 270:8158.
40. Savino, R., L. Ciapponi, A. Lahm, A. Demartis, A. Cabibbo, C. Toniatti, P. Delmastro, S. Altamura, and G. Ciliberto. 1994. Rational design of a receptor super-antagonist of human interleukin-6. EMBO J. 13:5863.
41. Hibi, M., M. Murakami, M. Saito, T. Hirano, T. Taga, and T. Kishimoto. 1990. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63: 1149.
42. Zohlnhöfer, D., L. Graeve, S. Rose-John, H. Schooltink, E. Dittrich, and P. C. Heinrich. 1992. The hepatic interleukin-6-receptor: down-regulation of the interleukin-6-binding subunit (gp80) by its ligand. FEBS Lett. 306:219.
43. Dinarello, C. A. 1991. Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627.
44. Gavrilova, O., V. Barr, B. Marcus-Samuels, and M. Reitman. 1997. Hyperleptinemia of pregnancy associated with the appearance of a circulating form of the leptin receptor. J. Biol. Chem. 272:30546.
45. Talamantes, F. 1994. The structure and regulation of expression of the mouse growth hormone receptor and binding protein. Proc. Soc. Exp. Biol. Med. 206: 254.
46. Heaney, M. L., and D. W. Golde. 1996. Soluble cytokine receptors. Blood 87: 847.